Brady Bernard

Cancer Institute (WIA)

Full Professor(heuristic)

Cancer Genomics and Diagnostics · Cancer Research

h-index55

i10-index69

Publications172

Citations66,015

Grants

No NSF/NIH grants on record.

Lab Funding Health

Find elsewhere

Institution / lab homepage Search on ResearchGate

In-Field Influence

0.0007

PageRank within Cancer Research co-authorship network

Explore collaboration map

Admission Signals

New paper: A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of soft tissue sarcoma (bioRxiv (Cold Spring Harbor Laboratory))2025-12-05
New preprint: Novel multiplex immunofluorescence-based tumor inflammation score provides apparent predictive biomarker in a phase I/II study of pembrolizumab with gemcitabine in patients with previously-treated advanced non-small cell lung cancer (NSCLC)2024-12-21

Data Freshness

Publications as of 2026-07-01
Grants as of 2026-06-30

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

ORCID: 0000-0003-2118-9829

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 14 of 14

A tailored in vivo CRISPR screen identifies BAP1 as a potent tumor suppressor of soft tissue sarcoma
bioRxiv (Cold Spring Harbor Laboratory) · 2025-12-05
636 Addition of GITR agonist to a dark matter cancer vaccine and anti-PD-1 increases regulatory T cell numbers without appearing to impact therapeutic efficacy
Regular and Young Investigator Award Abstracts · 2025-11-01
Multi-cancer comparative multi-omics approach reveals a permissive tumor microenvironment in renal cell carcinoma through accumulation of exhausted CD8+ and CD4+CD8+ double positive T cells 2661
The Journal of Immunology · 2025-11-01
Identification of a TCR to a non-canonical peptide (NCP) presented by the autologous non-small cell lung cancer (NSCLC) following an immunotherapy that includes canonical and NCPs 3338
The Journal of Immunology · 2025-11-01 · 1 citations
Fluorescence tracking identifies T cell movement from lymph nodes to irradiated tumors and mechanisms of T cell retention during post-radiation refilling 3240
The Journal of Immunology · 2025-11-01
Phenotypic and clonal evolution of CD4 T cells in HNSCC during immunotherapy: a case report 3277
The Journal of Immunology · 2025-11-01
The responses of HNSCC patients to immunotherapy are shown by two novel co-expression patterns
npj Precision Oncology · 2025-07-01 · 2 citations
Abstract 4716: Functional precision medicine: Uncovering high actionability in rare cancers beyond genomics
Cancer Research · 2025-04-21
Abstract 6707: Direct in vivo CRISPR screen identifies BAP1 and FAT1 as potent tumor suppressors in sarcomagenesis
Cancer Research · 2025-04-21
Abstract A025: Direct in vivo CRISPR screen identifies BAP1 and FAT1 as potent tumor suppressors in sarcomagenesis
Cancer Research · 2025-03-11
Association between ex vivo pharmacotyping of patient-derived tumor organoids and personalized therapeutic options for patients with biliary tract cancer.
Journal of Clinical Oncology · 2025-01-27 · 1 citations
Novel multiplex immunofluorescence-based tumor inflammation score provides apparent predictive biomarker in a phase I/II study of pembrolizumab with gemcitabine in patients with previously-treated advanced non-small cell lung cancer (NSCLC)Preprint
OncoImmunology · 2024-12-21
A novel small molecule Enpp1 inhibitor improves tumor control following radiation therapy by targeting stromal Enpp1 expression
Scientific Reports · 2024-12-02 · 7 citations
1481 Off-the-shelf dark matter immunotherapy in head & neck cancer: mechanistic insights and clinical efficacy
2024-11-01 · 1 citations

Open author page on OpenAlex →